Chapter 23 Pigmented Skin Lesion in a 58-Year-Old Female (Case 12)
Basal cell carcinoma | Malignant melanoma | Actinic keratosis |
Squamous cell carcinoma | Atypical nevus | Benign nevus |
When I’m asked to see a 48-year-old female who presents with an abnormal screening mammogram, I ask if the mammogram was truly a screening mammogram or was it prompted because the patient or her physician discovered an abnormality in her breast. I inquire about associated symptoms (e.g., nipple discharge, lumpiness, skin changes, or tenderness) and I determine menstrual hx. I probe for risk factors (e.g., family hx of breast cancer or previous biopsies). Most nonpalpable abnormalities found on mammography that are suspicious for malignancy will require an image-guided biopsy (stereotactic, ultrasound-guided, or needle-guided excisional biopsy) for dx so I try to prepare the patient for this at first consultation.
PATIENT CARE
Clinical Thinking
History
Of particular interest in patients presenting with a skin lesion are the following:
Physical Examination
Tests for Consideration
The following tests should be considered when planning biopsy of a skin lesion:
The following tests should be considered when planning a lymph node biopsy:
$1,000 | |
$650 |
The following tests should be considered when working up a biopsy-proven melanoma: | |
$75 | |
$1,500 | |
→ Positron emission tomography (PET): The positron-emitting isotope of glucose is highly sensitive to melanoma. Hour-long scanning of the entire body should be purposely modified to evaluate skin and deep tissues.
![]() Stay updated, free articles. Join our Telegram channel![]() Full access? Get Clinical Tree![]() ![]() ![]() |